Fabrizi, F., Cerutti, R., Dixit, V., & Ridruejo, E. (2021). Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysis. Web
Citación estilo ChicagoFabrizi, Fabrizio, Roberta Cerutti, Vivek Dixit, and Ezequiel Ridruejo. Sofosbuvir-based Regimens for HCV in Stage 4–stage 5 Chronic Kidney Disease. A Systematic Review With Meta-analysis. 2021.
Cita MLAFabrizi, Fabrizio, Roberta Cerutti, Vivek Dixit, and Ezequiel Ridruejo. Sofosbuvir-based Regimens for HCV in Stage 4–stage 5 Chronic Kidney Disease. A Systematic Review With Meta-analysis. 2021.
Precaución: Estas citas no son 100% exactas.